demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 hospitalized
COVID-19 severe or critically
Immunostimulants drugs
convalescent plasma treatment CAPSID PICP19 ... AlQahtani Ray Li REMAP-CAP ... Rasheed RECOVER Pouladzadeh CP-COVID-19 O’Donnell ILBS-COVID-02 ... PlasmAr Sekine ...
immunoglobulin therapy Raman Tabarsi Gharebaghi
interferon
IFN beta-1a Davoudi-Monfared Kalil ... Darazam ...
IFN beta-1b Darazam ... Rahmani
neutralizing antibody
equine polyclonal antibodies INM005 Lopardo

17 studies excluded by filtering options 1

4861 Cai -FAVIPIRAVIR, 2020 1310not a RCTrisk of bias not avaialble
5183 Qiong Zhou, 2020 0190selection pending
5406 Duan, 2020 1134not a RCThigh risk of bias
5446 Sean, 2020 1134not a RCThigh risk of bias
5450 Pereda, 0 0100selection pending
5534 Wang (early IFN), 2020 0134selection pending
5549 Hegerova, 2020 1134not a RCThigh risk of bias
5550 Abolghasemi, 2020 1134not a RCThigh risk of bias
5565 Pereda, 2020 0130selection pending
5569 Dai W, 2020 2134excludednot a RCThigh risk of bias
5572 Hao, 2020 0200selection pending
5662 Salazar, 2020 1134not a RCThigh risk of bias
5761 Joyner, 2020 1313not a RCThigh risk of bias
6140 Wang, 2020 0130selection pending
6159 Gemici, 2020 0130selection pending
6708 Webb, 2021 0130selection pending
6940 Bihariesingh-Sanchit (SuriCovid), 2021 1310not a RCTrisk of bias not avaialble